Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Traci Lyons

Concepts (224)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Semaphorins
9
2025
37
5.500
Why?
Antigens, CD
10
2025
562
4.620
Why?
Breast Neoplasms
26
2025
2420
4.600
Why?
Mammary Glands, Animal
9
2025
128
2.530
Why?
Lymphatic Vessels
6
2024
63
2.510
Why?
Mammary Glands, Human
6
2024
71
2.420
Why?
Postpartum Period
11
2022
379
2.100
Why?
Cyclooxygenase 2
6
2020
167
1.930
Why?
Carcinoma, Intraductal, Noninfiltrating
2
2025
61
1.350
Why?
Breast
6
2024
157
1.310
Why?
Macrophages
5
2025
1529
1.250
Why?
GPI-Linked Proteins
8
2025
81
1.210
Why?
Carcinoma, Ductal, Breast
2
2025
91
0.960
Why?
Gene Expression Regulation, Neoplastic
6
2022
1457
0.940
Why?
Epithelial Cells
4
2024
1141
0.930
Why?
Cell Line, Tumor
14
2025
3565
0.910
Why?
Lymphangiogenesis
4
2024
27
0.880
Why?
B7-H1 Antigen
2
2025
246
0.870
Why?
Cell Plasticity
1
2025
37
0.860
Why?
Transforming Growth Factor beta1
1
2025
177
0.830
Why?
Tumor Microenvironment
9
2025
748
0.820
Why?
Immune Tolerance
1
2025
386
0.740
Why?
Puerperal Disorders
2
2014
36
0.690
Why?
Receptors, Estrogen
3
2021
406
0.690
Why?
Anoikis
1
2021
31
0.680
Why?
Mammary Neoplasms, Animal
3
2016
35
0.670
Why?
Mice
21
2025
18491
0.640
Why?
Antineoplastic Agents, Hormonal
2
2020
196
0.640
Why?
Neoplasm Metastasis
6
2025
695
0.640
Why?
Pregnancy Complications, Neoplastic
4
2026
64
0.630
Why?
Extracellular Matrix
5
2021
566
0.630
Why?
Animals
26
2025
38410
0.550
Why?
Drug Resistance, Neoplasm
2
2021
889
0.550
Why?
Lactation
4
2022
195
0.510
Why?
Programmed Cell Death 1 Receptor
1
2019
268
0.500
Why?
Neoplasm Invasiveness
6
2025
512
0.490
Why?
NF-kappa B
1
2019
676
0.460
Why?
Female
31
2026
80076
0.440
Why?
Proto-Oncogene Proteins c-akt
3
2021
440
0.420
Why?
Disease Models, Animal
6
2025
4604
0.420
Why?
Aging
1
2025
1992
0.410
Why?
Biomarkers, Tumor
2
2020
1339
0.410
Why?
Neoplasm Recurrence, Local
1
2020
1166
0.400
Why?
Pregnancy
11
2026
7274
0.380
Why?
Cell Movement
6
2022
966
0.370
Why?
Xenograft Model Antitumor Assays
4
2020
939
0.370
Why?
Carcinoma, Ductal
1
2011
10
0.340
Why?
Fibrillar Collagens
1
2011
15
0.340
Why?
Collagen
3
2025
460
0.340
Why?
Mice, Knockout
4
2025
3153
0.330
Why?
Humans
34
2026
147293
0.330
Why?
Mice, Inbred BALB C
3
2019
1266
0.320
Why?
Disease Progression
4
2025
2890
0.300
Why?
Antigens, Differentiation, Myelomonocytic
2
2019
66
0.280
Why?
Cell Survival
2
2021
1111
0.260
Why?
Membrane Glycoproteins
2
2019
499
0.230
Why?
Mice, SCID
2
2020
369
0.230
Why?
Signal Transduction
6
2025
5272
0.230
Why?
Cell Transformation, Neoplastic
2
2021
340
0.230
Why?
Apoptosis
2
2020
2454
0.230
Why?
Ubiquitin-Protein Ligases
1
2007
199
0.220
Why?
Prognosis
4
2020
4383
0.220
Why?
Mice, Inbred C57BL
4
2021
6041
0.220
Why?
Mice, Inbred NOD
3
2021
616
0.210
Why?
Chitin
1
2024
9
0.210
Why?
Chitinases
1
2024
9
0.210
Why?
Lymphatic System
1
2024
15
0.200
Why?
Lymphatic Metastasis
4
2024
338
0.200
Why?
Epithelial-Mesenchymal Transition
1
2025
222
0.190
Why?
Celecoxib
2
2014
42
0.190
Why?
Biology
1
2024
89
0.190
Why?
Head and Neck Neoplasms
2
2020
569
0.190
Why?
Disease-Free Survival
2
2021
779
0.180
Why?
Immune Evasion
1
2022
63
0.180
Why?
Receptors, CXCR3
1
2022
17
0.180
Why?
Immunohistochemistry
2
2019
1730
0.180
Why?
Chemokine CXCL9
1
2022
38
0.180
Why?
Integrin alpha6
1
2021
9
0.170
Why?
Chemokine CXCL10
1
2022
39
0.170
Why?
Caspase 7
1
2021
22
0.170
Why?
Integrin beta1
1
2021
33
0.170
Why?
Gene Knockdown Techniques
2
2020
334
0.170
Why?
Melanoma, Experimental
1
2022
109
0.170
Why?
Triple Negative Breast Neoplasms
1
2024
220
0.170
Why?
Mammals
1
2022
286
0.160
Why?
Fibronectins
2
2020
136
0.160
Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
35
0.160
Why?
Caspase 3
1
2021
242
0.160
Why?
Cytoskeletal Proteins
1
2021
158
0.160
Why?
Actin Cytoskeleton
1
2021
103
0.160
Why?
Hyaluronan Receptors
1
2020
105
0.150
Why?
Enzyme Activation
1
2021
762
0.150
Why?
Adipocytes
1
2021
223
0.150
Why?
Models, Biological
3
2019
1772
0.150
Why?
Maternal Age
1
2020
129
0.150
Why?
Receptors, G-Protein-Coupled
1
2022
232
0.150
Why?
Kaplan-Meier Estimate
2
2020
975
0.150
Why?
Estrogens
2
2020
368
0.150
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
980
0.140
Why?
Mammary Neoplasms, Experimental
1
2019
62
0.140
Why?
Genes, Reporter
1
2019
278
0.140
Why?
Tumor Cells, Cultured
1
2020
891
0.140
Why?
Pyrazoles
2
2014
518
0.140
Why?
Sulfonamides
2
2014
596
0.140
Why?
Actins
1
2021
428
0.140
Why?
Phosphorylation
2
2021
1721
0.140
Why?
Crosses, Genetic
1
2018
123
0.140
Why?
Integrins
1
2018
90
0.130
Why?
Cell Proliferation
3
2020
2529
0.130
Why?
Extracellular Vesicles
1
2020
175
0.130
Why?
Antibodies, Monoclonal
1
2025
1514
0.130
Why?
RNA, Small Interfering
1
2020
643
0.130
Why?
Protein Binding
2
2022
2249
0.130
Why?
Podosomes
1
2016
4
0.120
Why?
Adaptor Proteins, Vesicular Transport
1
2016
46
0.120
Why?
Neoplasms
2
2026
2946
0.120
Why?
Neoplastic Stem Cells
1
2020
409
0.120
Why?
Genetic Pleiotropy
1
2016
34
0.120
Why?
rab GTP-Binding Proteins
1
2016
76
0.120
Why?
Survival Rate
1
2020
2110
0.110
Why?
Protein Kinase Inhibitors
1
2021
984
0.110
Why?
Melanoma
1
2022
774
0.110
Why?
Phenotype
2
2021
3216
0.100
Why?
Skin Neoplasms
1
2022
865
0.100
Why?
Blotting, Western
3
2011
1186
0.100
Why?
Dinoprostone
1
2014
180
0.100
Why?
CD8-Positive T-Lymphocytes
1
2019
932
0.090
Why?
CD4-Positive T-Lymphocytes
1
2019
1162
0.090
Why?
Endothelial Cells
1
2018
886
0.090
Why?
Drug Design
1
2013
177
0.090
Why?
Adult
7
2025
41405
0.090
Why?
Hematopoietic Stem Cells
1
2015
435
0.090
Why?
Ibuprofen
1
2011
87
0.080
Why?
Risk
2
2013
927
0.080
Why?
In Situ Hybridization, Fluorescence
1
2011
330
0.080
Why?
Time Factors
4
2020
7173
0.080
Why?
BRCA1 Protein
1
2010
83
0.070
Why?
Cohort Studies
1
2020
6099
0.070
Why?
Macrophage Activation
1
2010
181
0.070
Why?
Analysis of Variance
1
2011
1302
0.070
Why?
Stromal Cells
1
2009
123
0.070
Why?
Mutation
1
2019
4130
0.070
Why?
Incidence
2
2020
2954
0.070
Why?
Tamoxifen
1
2009
193
0.070
Why?
Extracellular Matrix Proteins
1
2009
156
0.070
Why?
Gonadal Steroid Hormones
1
2009
143
0.070
Why?
Insulin-Like Growth Factor I
1
2010
318
0.060
Why?
Restriction Mapping
1
2007
81
0.060
Why?
Intercellular Signaling Peptides and Proteins
1
2009
376
0.060
Why?
Disease Susceptibility
1
2009
347
0.060
Why?
Cloning, Molecular
1
2007
539
0.060
Why?
Estradiol
1
2010
515
0.060
Why?
Cell Line
2
2010
2832
0.060
Why?
Recombinant Fusion Proteins
1
2007
669
0.050
Why?
Phosphatidylinositol 3-Kinases
2
2020
383
0.050
Why?
Base Sequence
1
2007
2175
0.050
Why?
Immunotherapy
2
2022
672
0.050
Why?
Molecular Sequence Data
1
2007
2886
0.050
Why?
Young Adult
3
2020
14437
0.050
Why?
Cell Cycle Proteins
2
2020
633
0.040
Why?
Antineoplastic Agents
1
2013
2231
0.040
Why?
Stress Fibers
1
2021
18
0.040
Why?
Focal Adhesions
1
2021
47
0.040
Why?
T-Lymphocytes, Cytotoxic
1
2022
179
0.040
Why?
Zinc Finger E-box-Binding Homeobox 1
1
2020
21
0.040
Why?
Lymphocytes, Tumor-Infiltrating
1
2022
156
0.040
Why?
Tumor Burden
1
2022
327
0.040
Why?
Feedback, Physiological
1
2020
80
0.040
Why?
Pregnancy-Associated Plasma Protein-A
1
2020
14
0.040
Why?
SOXB1 Transcription Factors
1
2020
67
0.040
Why?
Kidney
1
2007
1511
0.040
Why?
Cell Adhesion
1
2020
451
0.040
Why?
Proteomics
2
2020
1203
0.040
Why?
Cell Communication
1
2020
329
0.030
Why?
Parity
1
2019
112
0.030
Why?
Ki-67 Antigen
1
2019
120
0.030
Why?
Survival Analysis
1
2022
1386
0.030
Why?
Hyaluronic Acid
1
2020
226
0.030
Why?
Rats
3
2013
5613
0.030
Why?
Proteins
1
2024
1024
0.030
Why?
Monocytes
1
2020
539
0.030
Why?
Adaptor Proteins, Signal Transducing
1
2020
430
0.030
Why?
Neoplasm Proteins
1
2020
445
0.030
Why?
Matrix Metalloproteinase 2
1
2016
58
0.030
Why?
Global Health
1
2020
406
0.030
Why?
Matrix Metalloproteinase 9
1
2016
133
0.030
Why?
Breast Feeding
1
2020
447
0.030
Why?
Lymph Nodes
1
2019
514
0.030
Why?
Protein Domains
1
2016
313
0.030
Why?
Neoplasm Staging
1
2019
1492
0.030
Why?
Rats, Sprague-Dawley
2
2010
2542
0.020
Why?
Gene Expression Profiling
1
2020
1794
0.020
Why?
Bone Marrow
1
2015
310
0.020
Why?
Case-Control Studies
1
2020
3660
0.020
Why?
Cadherins
1
2013
204
0.020
Why?
Risk Factors
2
2019
11017
0.020
Why?
Liver
1
2020
1916
0.020
Why?
Middle Aged
3
2020
36821
0.020
Why?
MicroRNAs
1
2016
694
0.020
Why?
Weaning
1
2010
51
0.020
Why?
Receptor, IGF Type 1
1
2010
64
0.020
Why?
Immunoprecipitation
1
2010
149
0.020
Why?
Matrix Metalloproteinases
1
2010
95
0.020
Why?
Proportional Hazards Models
1
2013
1344
0.020
Why?
Multivariate Analysis
1
2013
1550
0.020
Why?
Mitogen-Activated Protein Kinase 1
1
2010
172
0.020
Why?
Fluorescent Antibody Technique
1
2010
365
0.020
Why?
Proteasome Endopeptidase Complex
1
2010
156
0.020
Why?
Species Specificity
1
2010
547
0.020
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2009
143
0.020
Why?
Protein Transport
1
2010
442
0.020
Why?
Biomarkers
2
2010
4351
0.020
Why?
Mice, Nude
1
2009
680
0.020
Why?
Cytokines
1
2015
2086
0.020
Why?
Cell Cycle
1
2010
600
0.020
Why?
Mass Spectrometry
1
2010
728
0.020
Why?
Recombinant Proteins
1
2010
1371
0.020
Why?
Cell Culture Techniques
1
2009
375
0.010
Why?
Fibroblasts
1
2009
1039
0.010
Why?
Cells, Cultured
1
2010
4169
0.010
Why?
Adolescent
1
2020
22825
0.010
Why?
Retrospective Studies
1
2013
17560
0.010
Why?
Male
1
2020
73950
0.010
Why?
Aged
1
2010
26514
0.000
Why?
Lyons's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)